Notably, the upregulation of CSF1 and CCL18—as identified in the TME of ALK-positive tumors —increases type 2 (M2) tumor-associated macrophages (TAM) which have tumorigenic functions and are known to contribute to immune evasion [50, 51]. Here, CCL18 is linked to neoplasm.